BD

Baban Dang

Director Director DIN 05267889
DIN 05267889 First appointment May 2012 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Baban Dang

Data last updated:

Baban Dang was a Director at Plasoron Biotech Private Limited (2012–2014) and Director at Axiom Overseas Private Limited (from 2019). The companies operate in Pharma.

DIN 05267889
Primary Designation Director
Industry Pharma
First Appointment 28 May 2012
Oldest Company Age 11 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Plasoron Biotech Private Limited U51909DL2012PTC236591
Director28 May 20122012₹24.46 Cr (FY 2024)Active
Axiom Overseas Private Limited U51101DL2015PTC279219
Director16 Jul 20192015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Axiom Overseas Private Limited
Plasoron Biotech Private Limited
Premium access

Shareholding and investment profile for Baban Dang

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Baban Dang

Baban Dang was first appointed on 28 May 2012 as Director at Plasoron Biotech Private Limited. The most recent appointment on record is 16 Jul 2019 at Axiom Overseas Private Limited.

Baban Dang held 2 earlier board appointments: Plasoron Biotech Private Limited (Director, 28 May 2012 to 05 Jun 2014); Axiom Overseas Private Limited (Director, from 16 Jul 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available